Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Treasury Shares (2016 - 2026)

Conmed filings provide 17 years of Treasury Shares readings, the most recent being $49.0 million for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 237.98% to $49.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $49.0 million, a 237.98% increase, with the full-year FY2025 number at $12.9 million, down 17.53% from a year prior.
  • Treasury Shares hit $1.2 million in Q1 2026 for Conmed, up from $328097.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.8 million in Q1 2022 to a low of $46000.0 in Q4 2022.
  • Median Treasury Shares over the past 5 years was $508028.0 (2024), compared with a mean of $585810.0.
  • Biggest five-year swings in Treasury Shares: plummeted 60.86% in 2022 and later soared 237.98% in 2026.
  • Conmed's Treasury Shares stood at $22.8 million in 2022, then crashed by 34.2% to $15.0 million in 2023, then grew by 4.27% to $15.6 million in 2024, then fell by 17.53% to $12.9 million in 2025, then surged by 280.55% to $49.0 million in 2026.
  • The last three reported values for Treasury Shares were $49.0 million (Q1 2026), $12.9 million (Q4 2025), and $13.5 million (Q3 2025) per Business Quant data.